Xuri Li

National Eye Institute, NIH

Affiliated withNIH National Eye Institute

Research Area

NeuroscienceMedicine

Biography

Xuri Li has not added Biography.
If you are Xuri Li and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 2	Year
Publication title	2011
Publication title	2011

Other Publications

Article	Year
Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. Journal of the American Society of Nephrology : JASN\| PubMed ID: 11912250	2002
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 12374780	2002
PDGF-D is a potent transforming and angiogenic growth factor. Oncogene\| PubMed ID: 12629513	2003
Novel PDGF family members: PDGF-C and PDGF-D. Cytokine & growth factor reviews\| PubMed ID: 12651221	2003
Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. The American journal of pathology\| PubMed ID: 12875986	2003
Tissue plasminogen activator is a potent activator of PDGF-CC. The EMBO journal\| PubMed ID: 15372073	2004
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. The Journal of clinical investigation\| PubMed ID: 15630451	2005
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. The Journal of clinical investigation\| PubMed ID: 18259607	2008
Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 18511699	2008
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer research\| PubMed ID: 19118022	2009
A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Molecular and cellular biology\| PubMed ID: 19255141	2009
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19369214	2009
VEGF-B: a survival, or an angiogenic factor? Cell adhesion & migration\| PubMed ID: 19684473	2009
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. The Journal of biological chemistry\| PubMed ID: 20231273	2010
Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. The Journal of experimental medicine\| PubMed ID: 20231377	2010
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Molecular and cellular biology\| PubMed ID: 20385769	2010
VEGF-B: a thing of beauty. Cell research\| PubMed ID: 20531376	2010
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20566880	2010
Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood\| PubMed ID: 20606164	2010
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood\| PubMed ID: 20625009	2010
VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget\| PubMed ID: 20871734	2010
Complicated life, complicated VEGF-B. Trends in molecular medicine\| PubMed ID: 22178229	2012
Targeting of junctional adhesion molecule-C (JAM-C) inhibits experimental choroidal neovascularization. Investigative ophthalmology & visual science\| PubMed ID: 22323465	2012